DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Miller AA et al.
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
J Clin Oncol 2009;
27 (11) 1800-1805
We do not assume any responsibility for the contents of the web pages of other providers.